The Biostatistics Core provides long-term collaborative support to established programs of research at theCenter, and short-term consulting services. The work of the Core enhances the scientific objectives of theCenter's research programs by providing expertise on study design and statistical analysis. The field ofbiostatistics is devoted to developing an understanding of the appropriate ways to derive scientific inferencesfrom quantitative data, and to developing methods for achieving this aim. Our staff is highly trained in thisfield and were all recruited after extensive national searches. The Facility consists of 16 doctoral-levelfaculty biostatisticians, assisted by 8 masters-level biostatisticians, and a team of programming andadministrative staff. The doctoral-level biostatisticians in the Facility have broad, collective experience in allof the specialized areas of statistical techniques that are pertinent to contemporary cancer research,including clinical trials methodology, actuarial techniques, epidemiologic methods, analysis of genomicsdata, statistical genetics, methods for diagnostic medicine, evidence-based medicine and psychometricmethods. Cost recovery is achieved primarily through involvement of the Facility members and staff asfunded co-investigators on NIH grants. By providing a valid framework for the design, conduct and analysisof scientific studies, the Core contributes to scientific quality and promotes interdisciplinary research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-43
Application #
7671836
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-31
Project End
2012-12-31
Budget Start
2008-07-31
Budget End
2008-12-31
Support Year
43
Fiscal Year
2008
Total Cost
$494,764
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Kirov, Assen S; Fanchon, Louise M; Seiter, Daniel et al. (2018) Technical Note: Scintillation well counters and particle counting digital autoradiography devices can be used to detect activities associated with genomic profiling adequacy of biopsy specimens obtained after a low activity 18 F-FDG injection. Med Phys 45:2179-2185
Hayes, Sara A; Huang, James; Golia Pernicka, Jennifer et al. (2018) Radiographic Predictors of Resectability in Thymic Carcinoma. Ann Thorac Surg 106:242-248
Sobhani, Navid; Roviello, Giandomenico; Corona, Silvia P et al. (2018) The prognostic value of PI3K mutational status in breast cancer: A meta-analysis. J Cell Biochem 119:4287-4292
Park, Jae H; Romero, F Andres; Taur, Ying et al. (2018) Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells. Clin Infect Dis 67:533-540
Berhe, Simon; Danzer, Enrico; Meyers, Paul et al. (2018) Unusual abdominal metastases in osteosarcoma. J Pediatr Surg Case Rep 28:13-16
Dy, Benzon M; Katabi, Nora; Boucai, Laura et al. (2018) Follicular Carcinoma Masquerading as a Hot Nodule in a Pediatric Patient. Am Surg 84:1117-1119
Pareja, Fresia; Brandes, Alissa H; Basili, Thais et al. (2018) Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors. Nat Commun 9:3533
Yeoh, Cindy; Fischer, Gregory; Tollinche, Luis (2018) Arrest Under Anesthesia - What was the Culprit? A Case Report. EC anaesth 4:372-375
Lendvai, Nikoletta; Tsakos, Ioanna; Devlin, Sean M et al. (2018) Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity. Leuk Lymphoma 59:1981-1985
Bombard, Yvonne; Clausen, Marc; Mighton, Chloe et al. (2018) The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results. Eur J Hum Genet 26:984-995

Showing the most recent 10 out of 8799 publications